Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: a study based on bioinformatics analysis and meta-analysis

C Liu, Y Shen, Q Tan - The International Journal of …, 2023 - journals.sagepub.com
This study aims to explore the expression of matrix metalloproteinase-9 (MMP-9) associated
with both diagnostic and prognostic value in ovarian cancer by meta-analysis and …

Clinical manifestations and risk factors for complications of Philadelphia chromosome-negative myeloproliferative neoplasms

B Duangnapasatit, E Rattarittamrong… - Asian Pacific Journal …, 2015 - koreascience.kr
Background: Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell
disorders characterized by proliferation of one or more myeloid lineages. Polycythemia vera …

[HTML][HTML] Ruxolitinib 对JAK2V617F 阳性骨髓增殖性肿瘤细胞基质金属蛋白酶调控的研究

刘贵敏, 张丽军, 付建珠, 梁文同, 成志勇… - Chinese Journal of …, 2017 - ncbi.nlm.nih.gov
Ruxolitinib对JAK2V617F阳性骨髓增殖性肿瘤细胞基质金属蛋白酶调控的研究- PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Potential biomarkers and immune characteristics for polycythemia vera-related atherosclerosis using bulk RNA and single-cell RNA datasets: a combined …

Z Wang, J Zou - Frontiers in Cardiovascular Medicine, 2024 - frontiersin.org
Background Polycythemia vera (PV) is a myeloproliferative disease characterized by
significantly higher hemoglobin levels and positivity for JAK2 mutation. Thrombosis is the …

Clinico-epidemiological profile of patients with polycythaemia rubra vera-A five year experience from a tertiary care center

S Sultan, SM Irfan, S Murad - Asian Pacific Journal of Cancer …, 2016 - journal.waocp.org
Background: Polycythaemia rubra vera (PV) is a Philadelphia chromosome negative
myeloproliferative neoplasm characterized by increased red cell production, independent of …

Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells

GM Liu, LJ Zhang, JZ Fu, WT Liang… - Zhonghua xue ye xue …, 2017 - europepmc.org
Objective: To investigate the regulation of JAK2 tyrosine kinase inhibitor ruxolitinib on
extracellular matrix metalloproteinase (MMP in JAK2V617F positive myeloproliferative …

[HTML][HTML] 芦可替尼通过骨髓源性外泌体抑制原发性骨髓纤维化的血管新生

梁嘉怡, 李琼琼, 陆丽娜, 成志勇, 王素云 - 海军军医大学学报, 2024 - html.rhhz.net
目的探究芦可替尼能否在外泌体层面通过抑制血管新生减缓原发性骨髓纤维化(PMF) 发展.
方法采集3 例初诊PMF 患者治疗前(初诊组) 和芦可替尼治疗3 个月后(芦可替尼组) 及3 …

Acquired JAK-2 V617F mutational analysis in Pakistani patients with essential thrombocythemia

S Sultan, SM Irfan - Asian Pacific Journal of Cancer Prevention, 2015 - journal.waocp.org
Background: Essential thrombocythemia (ET) is a clonal hemopoietic stem cell
myeloproliferative neoplasmcharacterized by persistent thrombocytosis along with …

[HTML][HTML] Somatic JAK-2 V617F mutational analysis in polycythemia rubra vera: a tertiary care center experience

S Sultan, SM Irfan, SR Khan - Asian Pacific Journal of Cancer …, 2016 - koreascience.kr
Background: Polycythemia rubra vera (PV), being a primary polycythemia, is caused by
neoplastic proliferation of erythroid, megakaryocytic and granulocytic lineages which result …

[HTML][HTML] Primary Idiopathic Myelofibrosis: Clinico-Epidemiological Profile and Risk Stratification in Pakistani Patients

S Sultan, SM Irfan - Asian Pacific Journal of Cancer Prevention, 2016 - koreascience.kr
Background: Primary idiopathic myelofibrosis (PMF) is a clonal Philadelphia chromosome-
negative myeloproliferative neoplasm characterized by extramedullary hematopoiesis and …